Center Laboratories, Inc.
Records under this name other than the patents Center Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Center Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,980,935 | Method of treating hyperglycemia Lapsed on the fee record Ended May 29, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2026 | From the USPTO record |
| US 9,950,995 | Crystal forms of verapamil hydrochloride Lapsed on the fee record Ended Apr 24, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2026 | From the USPTO record |
| US 10,894,023 | Oral pH independent dosage formulation for treating neurodegenerative disorders Lapsed on the fee record Ended Jan 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2025 | From the USPTO record |
| US 10,639,292 | Method of treating hyperglycemia Lapsed on the fee record Ended May 5, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 5, 2024 | From the USPTO record |
| US 8,815,288 | Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders Lapsed on the fee record Ended Aug 26, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 26, 2022 | From the USPTO record |
| US 8,802,143 | Method for treating neurodegenerative disorders with oral dosage formulation containing both immediate-release and sustained-release drugs Lapsed on the fee record Ended Aug 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2022 | From the USPTO record |
| US 4,327,074 | Method for diagnosis and selective treatment of infections of bacteria having .beta.-glucuronidase activity Formerly held Term ended Term ended no later than Apr 27, 2002 · Low confidence | Term ended | Term ended no later than Apr 27, 2002 | Low confidence |
| US 4,337,760 | Method for the treatment of tumors with .beta.-glucuronidase activity dependent pharmaceuticals Formerly held Term ended Term ended no later than Jul 6, 2002 · Low confidence | Term ended | Term ended no later than Jul 6, 2002 | Low confidence |
| US 4,351,823 | Diagnosis of tumors or bacterial infections having .beta.-glucuronidase activity Formerly held Term ended Term ended no later than Sep 28, 2002 · Low confidence | Term ended | Term ended no later than Sep 28, 2002 | Low confidence |
| US 4,424,348 | Methods of manufacture of nitrile-containing glucuronic acid conjugates Formerly held Term ended Term ended no later than Jan 3, 2004 · Low confidence | Term ended | Term ended no later than Jan 3, 2004 | Low confidence |